US$ 29.29
dihexa cancer hgf c-met agonist Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor IS THERE A REAL RISK
Description
This interaction is mediated by dual binding, with FHD mainly binding to the p53 TAD and FOXO4 CR3 binding to the p53 DNA-binding domain (DBD) 38 (Figure

Jiang, L.-H., Shi, Y., Wang, L.-S

First we discuss exocrine pancreatic disease, in which cobalamin does not absorb in body as intrinsic factor is not there to facilitate the absorption

Saito, H
